IL146931A0 - Propargyl phenyl ether a2a receptor agonists - Google Patents

Propargyl phenyl ether a2a receptor agonists

Info

Publication number
IL146931A0
IL146931A0 IL14693100A IL14693100A IL146931A0 IL 146931 A0 IL146931 A0 IL 146931A0 IL 14693100 A IL14693100 A IL 14693100A IL 14693100 A IL14693100 A IL 14693100A IL 146931 A0 IL146931 A0 IL 146931A0
Authority
IL
Israel
Prior art keywords
receptor agonists
phenyl ether
propargyl phenyl
propargyl
agonists
Prior art date
Application number
IL14693100A
Other languages
English (en)
Original Assignee
Cv Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cv Therapeutics Inc filed Critical Cv Therapeutics Inc
Publication of IL146931A0 publication Critical patent/IL146931A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL14693100A 1999-06-22 2000-06-21 Propargyl phenyl ether a2a receptor agonists IL146931A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/338,183 US6180615B1 (en) 1999-06-22 1999-06-22 Propargyl phenyl ether A2A receptor agonists
PCT/US2000/017001 WO2000078777A1 (fr) 1999-06-22 2000-06-21 Agonistes du recepteur a2a de propargyl phenyl ether

Publications (1)

Publication Number Publication Date
IL146931A0 true IL146931A0 (en) 2002-08-14

Family

ID=23323754

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14693100A IL146931A0 (en) 1999-06-22 2000-06-21 Propargyl phenyl ether a2a receptor agonists
IL146931A IL146931A (en) 1999-06-22 2001-12-04 Propagil Phenyl receptor agonists A2A site

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL146931A IL146931A (en) 1999-06-22 2001-12-04 Propagil Phenyl receptor agonists A2A site

Country Status (21)

Country Link
US (1) US6180615B1 (fr)
EP (1) EP1192170B1 (fr)
JP (1) JP2003506459A (fr)
KR (1) KR100463693B1 (fr)
CN (1) CN1155608C (fr)
AR (1) AR024440A1 (fr)
AT (1) ATE240342T1 (fr)
AU (1) AU766799B2 (fr)
BR (1) BR0011850A (fr)
CA (1) CA2375385C (fr)
DE (1) DE60002723T2 (fr)
DK (1) DK1192170T3 (fr)
ES (1) ES2193975T3 (fr)
IL (2) IL146931A0 (fr)
MX (1) MXPA01013090A (fr)
NO (1) NO322096B1 (fr)
PT (1) PT1192170E (fr)
TR (1) TR200103752T2 (fr)
TW (1) TW558556B (fr)
WO (1) WO2000078777A1 (fr)
ZA (1) ZA200110553B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9914526A (pt) * 1998-10-16 2001-07-03 Pfizer Derivados de adenina
US7378400B2 (en) 1999-02-01 2008-05-27 University Of Virginia Patent Foundation Method to reduce an inflammatory response from arthritis
US6670334B2 (en) 2001-01-05 2003-12-30 University Of Virginia Patent Foundation Method and compositions for treating the inflammatory response
GB2372741A (en) 2001-03-03 2002-09-04 Univ Leiden C2,8-Disubstituted adenosine derivatives and their different uses
US7262176B2 (en) 2001-08-08 2007-08-28 Cv Therapeutics, Inc. Adenosine A3 receptor agonists
US20030078232A1 (en) * 2001-08-08 2003-04-24 Elfatih Elzein Adenosine receptor A3 agonists
SG176313A1 (en) 2001-10-01 2011-12-29 Univ Virginia Patent Found 2-propynyl adenosine analogs having a2a agonist activity and compositions thereof
WO2003051881A1 (fr) * 2001-12-17 2003-06-26 Ribapharm Inc. Banques de nucleosides purine et composes substitues par methodes combinatoires en phase solide
ATE348643T1 (de) 2002-02-15 2007-01-15 Cv Therapeutics Inc Polymerüberzug für medizinische vorrichtungen
WO2004022573A2 (fr) 2002-09-09 2004-03-18 Cv Therapeutics, Inc. Agonistes du recepteur de l'adenosine a3
TWI346109B (en) 2004-04-30 2011-08-01 Otsuka Pharma Co Ltd 4-amino-5-cyanopyrimidine derivatives
US7423144B2 (en) * 2004-05-26 2008-09-09 Inotek Pharmaceuticals Corporation Purine Derivatives as adenosine A1 receptor agonists and methods of use thereof
WO2006023272A1 (fr) 2004-08-02 2006-03-02 University Of Virginia Patent Foundation Analogues de 2-polycyclique propynyle adenosine presentant une activite agoniste de a2a
CA2576826C (fr) 2004-08-02 2014-09-30 University Of Virginia Patent Foundation Analogues de 2-propynyle adenosine comprenant des groupes 5'-ribose modifies presentant une activite agoniste a<sb>2a</sb>
BRPI0515506A (pt) * 2004-09-20 2008-07-29 Inotek Pharmaceuticals Corp derivados de purina e métodos de uso dos mesmos
BRPI0619261A2 (pt) * 2005-11-30 2011-09-27 Inotek Pharmaceuticals Corp derivados de purina e métodos de uso desses
US7589076B2 (en) * 2006-05-18 2009-09-15 Pgx Health, Llc Substituted aryl piperidinylalkynyladenosines as A2AR agonists
US7985754B2 (en) * 2006-07-17 2011-07-26 Trovis Pharmaceuticals, Llc Selective antagonists of A2A adenosine receptors
CN101516882B (zh) * 2006-07-17 2012-08-29 托维斯制药有限责任公司 A2a腺苷受体的选择性拮抗剂
CA2679257C (fr) 2007-02-28 2017-04-04 The Governors Of The University Of Alberta Composes destines a la prevention ou au traitement d'infections virales, et procedes d'utilisation de ceux-ci
LT2523669T (lt) 2010-01-11 2017-04-25 Inotek Pharmaceuticals Corporation Akispūdžio mažinimo būdas, derinys ir rinkinys
AU2011230580A1 (en) 2010-03-26 2012-10-11 Inotek Pharmaceuticals Corporation Method of reducing intraocular pressure in humans using N6 -cyclopentyladenosine (CPA), CPA derivatives or prodrugs thereof
PL2807178T3 (pl) 2012-01-26 2017-12-29 Inotek Pharmaceuticals Corporation Bezwodne polimorfy azotanu (2R,3S,4R,5R)-5-(6-(cyklopentyloamino)-9H-puryn-9-ylo)-3,4-dihydroksytetrahydrofuran-2-ylo)metylu i sposoby ich wytwarzania
WO2014152723A1 (fr) 2013-03-15 2014-09-25 Inotek Pharmaceuticals Corporation Formulations ophtalmiques

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK135130B (da) 1970-12-28 1977-03-07 Takeda Chemical Industries Ltd Analogifremgangsmåde til fremstilling af 2-substituerede adenosinderivater eller syreadditionssalte deraf.
JPS6299395A (ja) * 1985-10-25 1987-05-08 Yamasa Shoyu Co Ltd ２−アルキニルアデノシンおよび抗高血圧剤
DE68916036T2 (de) * 1988-11-15 1994-09-29 Toa Eiyo Ltd Mittel zur behandlung und prophylaxe koronarer und zerebraler ischämischer erkrankungen.
KR920700218A (ko) * 1989-06-20 1992-02-19 원본미기재 2-알키닐 아데노신의 합성중간체, 그 합성 중간체의 제조법, 그 합성중간체를 이용한 2-알키닐 아데노신의 제조법 및 안정한 2-알키닐 아데노신 유도체
US5189027A (en) * 1990-11-30 1993-02-23 Yamasa Shoyu Kabushiki Kaisha 2-substituted adenosine derivatives and pharmaceutical compositions for circulatory diseases
JP2740362B2 (ja) * 1991-02-12 1998-04-15 ヤマサ醤油株式会社 安定な固体状２‐オクチニルアデノシンおよびその製造法
IT1254915B (it) 1992-04-24 1995-10-11 Gloria Cristalli Derivati di adenosina ad attivita' a2 agonista
EP0601322A3 (fr) * 1992-10-27 1994-10-12 Nippon Zoki Pharmaceutical Co Inhibiteur de déaminase d'adénosine.
US5629298A (en) * 1995-03-13 1997-05-13 University Of Massachusetts Medical Center Adenosine as a positive inotrop in the compromised heart
US6376472B1 (en) * 1996-07-08 2002-04-23 Aventis Pharmaceuticals, Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
US5789416B1 (en) * 1996-08-27 1999-10-05 Cv Therapeutics Inc N6 mono heterocyclic substituted adenosine derivatives
US5770716A (en) * 1997-04-10 1998-06-23 The Perkin-Elmer Corporation Substituted propargylethoxyamido nucleosides, oligonucleotides and methods for using same

Also Published As

Publication number Publication date
NO20016349L (no) 2002-02-01
KR100463693B1 (ko) 2004-12-29
KR20020092158A (ko) 2002-12-11
CN1155608C (zh) 2004-06-30
CA2375385C (fr) 2006-02-14
ZA200110553B (en) 2003-10-21
AU766799B2 (en) 2003-10-23
EP1192170B1 (fr) 2003-05-14
AR024440A1 (es) 2002-10-02
DE60002723T2 (de) 2004-04-08
CA2375385A1 (fr) 2000-12-28
CN1358190A (zh) 2002-07-10
AU6053000A (en) 2001-01-09
IL146931A (en) 2006-06-11
PT1192170E (pt) 2003-09-30
DK1192170T3 (da) 2003-08-11
TW558556B (en) 2003-10-21
ATE240342T1 (de) 2003-05-15
TR200103752T2 (tr) 2002-04-22
ES2193975T3 (es) 2003-11-16
DE60002723D1 (en) 2003-06-18
US6180615B1 (en) 2001-01-30
WO2000078777A1 (fr) 2000-12-28
NO322096B1 (no) 2006-08-14
BR0011850A (pt) 2002-05-21
EP1192170A1 (fr) 2002-04-03
JP2003506459A (ja) 2003-02-18
MXPA01013090A (es) 2002-06-04
NO20016349D0 (no) 2001-12-21

Similar Documents

Publication Publication Date Title
IL147198A0 (en) N-pyrazole a2a receptor agonists
IL147195A0 (en) C-pyrazole a2a receptor agonists
ATE240342T1 (de) Propargylphenyl-äther a2a rezeptoragonisten
AU6497701A (en) Melanocortin receptor agonists
ZA200203450B (en) beta2-adrenergic receptor agonists.
HUP0401437A3 (en) Adenosine a3 receptor agonists
SG83721A1 (en) Beta 2-adrenergic receptor agonists
HUP0201658A2 (en) Beta2-adrenoceptor agonists
PL353969A1 (en) Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof as adenosine receptor ligands
HRP20010089B1 (en) 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists
PL351486A1 (en) Prrsv vaccines
IL146151A0 (en) Human-g-protein receptor
AU2001247227A1 (en) 2-thioether a2a receptor agonists
GB0015517D0 (en) Somatostatin agonists
PL352763A1 (en) Somatostatin agonists
GB2348390B (en) Interchangable handles
GB9915516D0 (en) Swivel ruler
SI1235787T1 (en) $g(b)2-ADRENERGIC RECEPTOR AGONISTS
TW534455U (en) Improved structure for heater
TW384769U (en) Improved structure for the pen knife
GB9906379D0 (en) Quick weigh
TW385677U (en) Improved structure for hanger rod
GB9923246D0 (en) Serex clones
TW392594U (en) Improved ruler structure
GB9907065D0 (en) Foam

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed